CLINICAL_TRIALS
trial_result
· 2023-12-27
Clinical Trial Update: A Study of IBI362 in Chinese Patients With Type 2 Diabetes [Phase 2]
Summary
Phase 2 clinical trial update for IBI362 in Chinese patients with Type 2 Diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED